Given the results presented here, we propose that the CCL21+ICAM1 synthetic niche, which proved to enhance expansion in the murine OVA systems, and elevate the cytotoxic capacity of murine CD8 cells, is capable to reinforce human TIL, derived from melanoma patients. The gene discussed is CCL21; the disease is melanoma.